|
High $0.26 |
Low $0.23 |
Trades 118 |
Turnover $129,465 |
Volume 540,651 |
| 30 June 2023 at 4:10pm | ||||
|
Market Cap (13-Nov) $8,636,608 (678th) |
Close (30-Jun) $0.250 |
Volume (30-Jun) 540,651 |
Shortsold (15-Sep) 153,602 (0.02%) (540th) |
|
52w High $0.056 |
52w Low $0.010 |
P/E 0.41 |
EPS -0.02 |
Appendix 3G
DTZ released this announcement to the ASX on 3 May 2021, 16:45. The announcement is not marked as price sensitive, and is 14 page(s) in length and 1.36MB in size.
You can view all announcements from DTZ and see how they appear on a price chart on the announcements page.
At the date of this announcement, DTZ was 0.001% short sold according to ASIC data. It was ranked the 643rd most shorted stock on the ASX. It is now ranked as the 540th most shorted stock on the ASX with 0.020% of total shares short sold as of the latest reported data (15 September 2026).
| Other Recent Announcements from DTZ | |
|---|---|
| Cleansing Statement | 30 June 2023, 10:35 |
| Application for quotation of securities - DTZ | 30 June 2023, 10:33 |
| Change of Director's Interest Notice - DE | 22 June 2023, 19:05 |
| Appendix 3G | 3 May 2021, 16:45 |
| Quarterly Report & Appendix 4C Cashflow Report - 31 March 21 | 3 May 2021, 9:19 |
| Dotz and Zohar Dalia Sign Supply and Distribution Agreements | 26 April 2021, 9:16 |
| DTZ Completes Clinical Trial and Submits FDA EUA Application | 7 April 2021, 10:13 |
If you were already registered, log in here.